Patents matching “recombinant”

US 9050285

Recombinant bacterium capable of eliciting an immune response against Streptococcus pneumoniae

The United States of America National Institutes of Health (NH), U.S. Dept. of Health and Human Services (DHHS) · Granted Jun 9, 2015 · Expires Jun 4, 2035

US 9045742

Recombinant Edwardsiella bacterium

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Jun 2, 2015 · Expires May 28, 2035

US 9040059

Recombinant bacterium capable of eliciting a protective immune response against C. perfringens

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted May 26, 2015 · Expires May 21, 2035

US 8993519

Method of treatment for neutropenia using stable formulations of recombinant human albumin-human granulocyte colony stimulating factor

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 31, 2015 · Expires Mar 26, 2035

US 8932846

Unmarked recombinant intracellular pathogen immunogenic compositions expressing high levels of recombinant proteins

The Regents of the University of California · Granted Jan 13, 2015 · Expires Jan 8, 2035

US 8900818

Recombinant antigen for diagnosis and prevention of murine typhus

United States of America as represented by the Secretary of the Air Force · Granted Dec 2, 2014 · Expires Nov 27, 2034

US 8895018

Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction

The United States of America as represented by the Department of Veteran Affairs · Granted Nov 25, 2014 · Expires Nov 20, 2034

US 8846057

Recombinant live attenuated foot-and-mouth disease (FMD) vaccine containing mutations in the L protein coding region

The United States of America, as represented by the Secretary of Agriculture · Granted Sep 30, 2014 · Expires Sep 25, 2034

US 8835386

Activity of recombinant equine follicle stimulating hormone

The Regents of the University of California · Granted Sep 16, 2014 · Expires Sep 11, 2034

US 8802836

Cloning and recombinant productions of Vespula venom protease and methods of use thereof

PLS-Design GmbH · Granted Aug 12, 2014 · Expires Aug 7, 2034

US 8802090

Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

PRECISION BIOLOGICS, INC. · Granted Aug 12, 2014 · Expires Aug 7, 2034

US 8685404

Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction

United States Government as represented by the Department of Veterans Affairs · Granted Apr 1, 2014 · Expires Mar 27, 2034

US 8673629

Recombinant Rift Valley fever (RVF) viruses and methods of use

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Mar 18, 2014 · Expires Mar 13, 2034

US 8663622

Recombinant vaccine viruses expressing IL-15 and methods using the same

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 4, 2014 · Expires Feb 27, 2034

US 8647633

Recombinant F1-V plague vaccine

The United States of America as represented by the Secretary of the Army · Granted Feb 11, 2014 · Expires Feb 6, 2034

US 8632782

Recombinant attenuated dengue viruses comprising mutations in NS5 and the 3′ untranslated region

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 21, 2014 · Expires Jan 16, 2034

US 8623383

Recombinant antigens for diagnosis and prevention of spotted fever rickettsiae

United States of America as represented by the Secretary of the Air Force · Granted Jan 7, 2014 · Expires Jan 2, 2034

US 8623614

Method for the recombinant production of magnetic nanoparticles

Ludwig-Maximilians-Universitat Munchen · Granted Jan 7, 2014 · Expires Jan 2, 2034

US 8597655

Recombinant fusion protein and polynucleotide construct for immunotoxin production

The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Dec 3, 2013 · Expires Nov 28, 2033

US 8568739

Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 29, 2013 · Expires Oct 24, 2033

US 8535667

Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

PRECISION BIOLOGICS, INC. · Granted Sep 17, 2013 · Expires Sep 12, 2033

US 8524247

Rabies virus-based recombinant immunocontraceptive compositions and methods of use

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Sep 3, 2013 · Expires Aug 29, 2033

US 8524456

Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

PRECISION BIOLOGICS, INC. · Granted Sep 3, 2013 · Expires Aug 29, 2033

US 8465755

Recombinant bacterium capable of eliciting an immune response against enteric pathogens

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Jun 18, 2013 · Expires Jun 13, 2033